Fiche du document
- doi: 10.1007/s11154-020-09612-2
- issn: 1389-9155
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11154-020-09612-2
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33169199
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1573-2606
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_57C21FC6421F3
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Tumours Neoplasms Knowledge, Classification ofCiter ce document
S. La Rosa et al., « Classification of neuroendocrine neoplasms: lights and shadows. », Serveur académique Lausannois, ID : 10.1007/s11154-020-09612-2
Métriques
Partage / Export
Résumé
Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplastic proliferations showing different morphological features, immunophenotype, molecular background, clinical presentation, and outcome. They can virtually originate in every organ of the human body and their classification is not uniform among different sites. Indeed, as they have historically been classified according to the organ in which they primarily arise, the different nomenclature that has resulted have created some confusion among pathologists and clinicians. Although a uniform terminology to classify neuroendocrine neoplasms arising in different systems has recently been proposed by WHO/IARC, some issues remain unsolved or need to be clarified. In this review, we discuss the lights and shadows of the current WHO classifications used to define and characterize NENs of the pituitary gland, lung, breast and those of the head and neck region, and digestive and urogenital systems.